|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
238,172,000 |
Market
Cap: |
2.94(B) |
Last
Volume: |
1,974,526 |
Avg
Vol: |
1,327,982 |
52
Week Range: |
$11.61 - $23.84 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : 12.3 |
Insider 6 Months : 12.3 |
Insider 3/6 Months : 24.3 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Neogen and subsidiaries develop, manufacture and market a range of products and services dedicated to food and animal safety. Co.'s segments are: Food Safety, which is engaged in the production and marketing of diagnostic test kits and complementary products marketed to food and feed producers and processors to detect dangerous and/or unintended substances in food and animal feed; and Animal Safety, which is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, a range of agricultural biosecurity products such as rodenticides, cleaners, disinfectants and insecticides, and genomics services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
53,000 |
53,000 |
76,000 |
143,100 |
Total Buy Value |
$662,087 |
$662,087 |
$1,009,714 |
$2,211,696 |
Total People Bought |
4 |
4 |
5 |
9 |
Total Buy Transactions |
4 |
4 |
7 |
17 |
Total Shares Sold |
0 |
0 |
6,359 |
6,359 |
Total Sell Value |
$0 |
$0 |
$109,734 |
$109,734 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
4 |
4 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Jones Douglas Edward |
Chief Operating Officer |
|
2024-04-25 |
4 |
D |
$11.96 |
$3,480 |
D/D |
(291) |
46,685 |
|
- |
|
Jones Douglas Edward |
Chief Operating Officer |
|
2024-04-25 |
4 |
OE |
$11.96 |
$10,106 |
D/D |
845 |
46,976 |
|
- |
|
Adent John Edward |
CEO |
|
2024-04-25 |
4 |
D |
$11.96 |
$7,355 |
D/D |
(615) |
171,364 |
|
- |
|
Adent John Edward |
CEO |
|
2024-04-25 |
4 |
OE |
$11.96 |
$25,271 |
D/D |
2,113 |
171,979 |
|
- |
|
Rocklin Amy M |
Chief Legal Officer |
|
2024-04-25 |
4 |
OE |
$11.96 |
$6,733 |
D/D |
563 |
10,456 |
|
- |
|
Adent John Edward |
CEO |
|
2024-04-23 |
4/A |
A |
$11.81 |
$211,369 |
D/D |
17,899 |
170,288 |
|
- |
|
Adent John Edward |
CEO |
|
2024-04-23 |
4 |
A |
$12.09 |
$211,297 |
D/D |
17,477 |
169,866 |
|
- |
|
Jones Douglas Edward |
Chief Operating Officer |
|
2024-04-17 |
4 |
B |
$12.36 |
$123,590 |
D/D |
10,000 |
46,131 |
2.74 |
4% |
|
Borel James C |
Director |
|
2024-04-11 |
4 |
B |
$13.06 |
$97,986 |
D/D |
7,500 |
21,392 |
2.39 |
-4% |
|
Adent John Edward |
CEO |
|
2024-04-10 |
4 |
B |
$12.36 |
$284,190 |
D/D |
23,000 |
152,389 |
2.74 |
-1% |
|
Naemura David H. |
CFO |
|
2024-04-10 |
4 |
B |
$12.51 |
$156,321 |
D/D |
12,500 |
30,040 |
2.74 |
-1% |
|
Jones Douglas Edward |
Chief Operating Officer |
|
2023-10-25 |
4 |
B |
$15.17 |
$151,727 |
D/D |
10,000 |
36,131 |
2.74 |
12% |
|
Lilly Jason Warren |
Vice President |
|
2023-10-13 |
4 |
S |
$15.10 |
$5,300 |
D/D |
(351) |
26,744 |
|
-10% |
|
Tobin James P |
Director |
|
2023-10-12 |
4 |
B |
$15.19 |
$45,567 |
D/D |
3,000 |
20,392 |
2.39 |
15% |
|
Boehm William T |
Director |
|
2023-10-11 |
4 |
S |
$15.61 |
$40,456 |
D/D |
(2,591) |
24,509 |
|
-15% |
|
Lilly Jason Warren |
Vice President |
|
2023-10-11 |
4 |
S |
$15.69 |
$30,087 |
D/D |
(1,917) |
25,944 |
|
-15% |
|
Naemura David H. |
CFO |
|
2023-10-11 |
4 |
B |
$15.03 |
$150,333 |
D/D |
10,000 |
10,000 |
2.74 |
15% |
|
Boehm William T |
Director |
|
2023-08-18 |
4 |
S |
$22.59 |
$33,891 |
D/D |
(1,500) |
24,509 |
|
9% |
|
Boehm William T |
Director |
|
2023-08-18 |
4 |
OE |
$15.62 |
$23,430 |
D/D |
1,500 |
26,009 |
|
- |
|
Hagedorn Jerome L |
Vice President, NA Operations |
|
2023-04-25 |
4 |
D |
$16.67 |
$3,234 |
D/D |
(194) |
2,571 |
|
- |
|
Adent John Edward |
President & CEO |
|
2023-04-25 |
4 |
D |
$16.67 |
$10,936 |
D/D |
(656) |
81,907 |
|
- |
|
Jones Douglas Edward |
Chief Operating Officer |
|
2023-04-25 |
4 |
D |
$16.67 |
$4,951 |
D/D |
(297) |
11,857 |
|
- |
|
Lilly Jason Warren |
Vice President, International |
|
2023-04-25 |
4 |
D |
$16.67 |
$6,468 |
D/D |
(388) |
21,506 |
|
- |
|
Boehm William T |
Director |
|
2023-01-26 |
4 |
OE |
$20.08 |
$15,060 |
D/D |
750 |
24,509 |
|
- |
|
Boehm William T |
Director |
|
2023-01-26 |
4 |
OE |
$15.62 |
$23,430 |
D/D |
1,500 |
25,259 |
|
- |
|
521 Records found
|
|
Page 1 of 21 |
|
|